For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...
The EU has agreed to cut protection for new drugs to allow cheaper generics on to the market a year earlier to curb the rise in public spending on health. But the pharmaceutical industry has warned ...
Nvidia isn’t just contributing chips to the effort to transform healthcare, says VP of healthcare Kimberly Powell. It’s ...
In this week’s edition of InnovationRx, we look at cancer treatment breakthroughs from ESMO, a high-tech chair that could revolutionize cancer radiation therapy, AI chatbots for seniors, a startup ...
The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and ...
Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...
In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...
STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new weight loss drugs on Black America. Jonathan Gustave was diagnosed with ...
Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...
Bills on diagnostic breast cancer testing, GLP-1 medications, lead paint and breastfeeding were signed into law.
A new class of life-saving drugs is helping children who once had no hope. But some carry a price tag of millions for a ...